1Accelerating the coordinated development of sub-specialties such as allergy,immunology and rheumatology of pediatric clinical immunology in ChinaZENG Hua-songEDITORIAL801-803,8802Application of pharmacogenomics in the treatment of chil-dren with rheumatic diseasesXU Xiao-lin, WANG Xiao-ling, MAO Hua-weiA CENTURY OF COMMITMENT TO PEOPLE'S HEALTH BY THE COMMUNIST PARTY OF CHINA·SYMPOSIUM804-8113Mechanisms of autoimmunity in patients with primary immunodeficiency disease and targeted therapiesWU Jun-feng, ZHAO Xiao-dong, AN Yun-feiA CENTURY OF COMMITMENT TO PEOPLE'S HEALTH BY THE COMMUNIST PARTY OF CHINA·SYMPOSIUM811-8164Appropriate application of intravenous immunoglobulin in pediatric rheumatic diseasesTANG Hong-xia, YIN WeiA CENTURY OF COMMITMENT TO PEOPLE'S HEALTH BY THE COMMUNIST PARTY OF CHINA·SYMPOSIUM816-8215Progress and suggestions in the treatment of macrophage activation syndrome associated with rheumatic diseases in childrenGUO Li, LU Mei-pingA CENTURY OF COMMITMENT TO PEOPLE'S HEALTH BY THE COMMUNIST PARTY OF CHINA·SYMPOSIUM822-8286Key points and advances in the treatment of systemic ju-venile idiopathic arthritisLI Xiao-qing, GENG Ling-lingA CENTURY OF COMMITMENT TO PEOPLE'S HEALTH BY THE COMMUNIST PARTY OF CHINA·SYMPOSIUM828-8327New advances in immunotherapy for allergic diseases in childrenBIAN Sai-nan, WANG Zi-xi, GUAN KaiA CENTURY OF COMMITMENT TO PEOPLE'S HEALTH BY THE COMMUNIST PARTY OF CHINA·SYMPOSIUM833-8388Advances of slow-acting antirheumatic drug for juvenile dermatomyositisLIU Li, SUN Yan-ru, HU JianA CENTURY OF COMMITMENT TO PEOPLE'S HEALTH BY THE COMMUNIST PARTY OF CHINA·SYMPOSIUM839-8429Advances in chronic disease management and Treatment of cSLE and LNJIANG Xin-hui, SHAO Xiao-shanA CENTURY OF COMMITMENT TO PEOPLE'S HEALTH BY THE COMMUNIST PARTY OF CHINA·SYMPOSIUM842-84810Application of Th2 inhibitor in childhood allergic and im-mune diseasesXU Xue-feng, CHEN Xiang-yuan, ZENG Hua-songA CENTURY OF COMMITMENT TO PEOPLE'S HEALTH BY THE COMMUNIST PARTY OF CHINA·SYMPOSIUM849-85311JAK inhibitors as small molecule targeted agents in the treatment of children with rheumatic and immune diseasesHAO Sheng, HUANG Wen-yan, ZENG Hua-songA CENTURY OF COMMITMENT TO PEOPLE'S HEALTH BY THE COMMUNIST PARTY OF CHINA·SYMPOSIUM853-85712Efficacy and safety analysis of belimumab for 28 weeks in real-world Chinese children with systemic lupus ery-thematosus:a retrospective multicenter pilot studyMulti-center Research Collaboration Group,Pediatric Allergy Immunology Rheumatology Branchthe Asia-Pacific Association of Medicine and Bio-Immunology,(PAIRB-APAMBI), Editorial Committee of Chinese Journal of Practical PediatricsORIGINAL CONTRIBUTION858-86813Clinical analysis of peritoneal dialysis in the treatment of acute kidney injury in extremely low birth weight infantsCAO Guang-na, ZHANG Jing, PIAO Mei-huaORIGINAL CONTRIBUTION869-873